U.S. flag

An official website of the United States government

NM_000369.5(TSHR):c.1657G>T (p.Ala553Ser) AND TSHR-related disorder

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Dec 6, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004531768.1

Allele description

NM_000369.5(TSHR):c.1657G>T (p.Ala553Ser)

Gene:
TSHR:thyroid stimulating hormone receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q31.1
Genomic location:
Preferred name:
NM_000369.5(TSHR):c.1657G>T (p.Ala553Ser)
HGVS:
  • NC_000014.9:g.81143715G>T
  • NG_009206.1:g.193191G>T
  • NM_000369.5:c.1657G>TMANE SELECT
  • NP_000360.2:p.Ala553Ser
  • NP_000360.2:p.Ala553Ser
  • LRG_523t1:c.1657G>T
  • LRG_523:g.193191G>T
  • LRG_523p1:p.Ala553Ser
  • NC_000014.8:g.81610059G>T
  • NM_000369.2:c.1657G>T
Protein change:
A553S
Molecular consequence:
  • NM_000369.5:c.1657G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
TSHR-related disorder
Synonyms:
TSHR-Related Disorders; TSHR-related condition
Identifiers:

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV004113845PreventionGenetics, part of Exact Sciences
criteria provided, single submitter

(ACMG Guidelines, 2015)		Uncertain significance
(Dec 6, 2023) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From PreventionGenetics, part of Exact Sciences, SCV004113845.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The TSHR c.1657G>T variant is predicted to result in the amino acid substitution p.Ala553Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0018% of alleles in individuals of European (Non-Finnish) descent in gnomAD. However, a different missense variant impacting the same amino acid residue, p.Ala553Thr, has been reported in homozygous and compound heterozygous individuals with a hypothyroidism phenotype (Abramowicz et al. 1997. PubMed ID: 9185526; Park et al. 2004. PubMed ID: 14725684). Taken together, while we suspect that the c.1657G>T (p.Ala553Ser) variant could be pathogenic, at this time we interpret its clinical significance as uncertain due to the absence of conclusive functional and genetic evidence.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024